Literature DB >> 11413343

Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.

L Doukhan1, E Delwart.   

Abstract

Monitoring the evolution of human immunodeficiency virus type 1 (HIV-1) drug resistance requires measuring the frequency of closely related genetic variants making up the complex viral quasispecies found in vivo. In order to resolve both major and minor (>/=2%) protease gene variants differing by one or more nucleotide substitutions, we analyzed PCR products derived from plasma viral quasispecies by using a combination of denaturing gradient gel electrophoresis and DNA heteroduplex tracking assays. Correct population sampling of the high level of genetic diversity present within viral quasispecies could be documented by parallel analysis of duplicate, independently generated PCR products. The composition of genetically complex protease gene quasispecies remained constant over short periods of time in the absence of treatment and while plasma viremia fell >100-fold following the initiation of protease inhibitor ritonavir monotherapy. Within a month of initiating therapy, a strong reduction in the genetic diversity of plasma viral populations at the selected protease locus was associated with rising plasma viremia and the emergence of drug resistance. The high levels of protease genetic diversity seen before treatment reemerged only months later. In one patient, reduction in genetic diversity at the protease gene was observed concomitantly with an increase in diversity at the envelope gene (E. L. Delwart, P. Heng, A. Neumann, and M. Markowitz, J. Virol. 72:2416-2421, 1998), indicating that opposite population genetic changes can take place in different HIV-1 loci. The rapid emergence of drug-resistant HIV-1 was therefore associated with a strong, although only transient, reduction in genetic diversity at the selected locus. The denaturing gradient-heteroduplex tracking assay is a simple method for the separation and quantitation of very closely related, low-frequency, genetic variants within complex viral populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413343      PMCID: PMC114399          DOI: 10.1128/JVI.75.14.6729-6736.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  HIV quasispecies and resampling.

Authors:  S L Liu; A G Rodrigo; R Shankarappa; G H Learn; L Hsu; O Davidov; L P Zhao; J I Mullins
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

2.  Ordered accumulation of mutations in HIV protease confers resistance to ritonavir.

Authors:  A Molla; M Korneyeva; Q Gao; S Vasavanonda; P J Schipper; H M Mo; M Markowitz; T Chernyavskiy; P Niu; N Lyons; A Hsu; G R Granneman; D D Ho; C A Boucher; J M Leonard; D W Norbeck; D J Kempf
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

3.  Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure.

Authors:  L Moutouh; J Corbeil; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects.

Authors:  W J Lech; G Wang; Y L Yang; Y Chee; K Dorman; D McCrae; L C Lazzeroni; J W Erickson; J S Sinsheimer; A H Kaplan
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission.

Authors:  T Zhu; N Wang; A Carr; D S Nam; R Moor-Jankowski; D A Cooper; D D Ho
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor.

Authors:  M Markowitz; H Mo; D J Kempf; D W Norbeck; T N Bhat; J W Erickson; D D Ho
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.

Authors:  R E Dickover; E M Garratty; S A Herman; M S Sim; S Plaeger; P J Boyer; M Keller; A Deveikis; E R Stiehm; Y J Bryson
Journal:  JAMA       Date:  1996-02-28       Impact factor: 56.272

8.  Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants.

Authors:  K Nielsen; P Boyer; M Dillon; D Wafer; L S Wei; E Garratty; R E Dickover; Y J Bryson
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

9.  Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

Authors:  R Schuurman; M Nijhuis; R van Leeuwen; P Schipper; D de Jong; P Collis; S A Danner; J Mulder; C Loveday; C Christopherson
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

10.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

View more
  10 in total

1.  Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques.

Authors:  Magdalena Magierowska; Flavien Bernardin; Seema Garg; Silvija Staprans; Michael D Miller; Koen K A Van Rompay; Eric L Delwart
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Inferring viral population structures using heteroduplex mobility and DNA sequence analyses.

Authors:  Raj Shankarappa; James I Mullins
Journal:  J Virol Methods       Date:  2013-08-29       Impact factor: 2.014

3.  Female genital tract shedding of CXCR4-tropic HIV Type 1 is associated with a majority population of CXCR4-tropic HIV Type 1 in blood and declining CD4(+) cell counts.

Authors:  Richard E Haaland; Sharon T Sullivan; Tammy Evans-Strickfaden; Jeffrey L Lennox; Clyde E Hart
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

4.  Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status.

Authors:  Sharon T Sullivan; Usha Mandava; Tammy Evans-Strickfaden; Jeffrey L Lennox; Tedd V Ellerbrock; Clyde E Hart
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Wide range of quasispecies diversity during primary hepatitis C virus infection.

Authors:  Belinda L Herring; Rose Tsui; Lorraine Peddada; Michael Busch; Eric L Delwart
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection.

Authors:  Kathryn M Kitrinos; Noah G Hoffman; Julie A E Nelson; Ronald Swanstrom
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects.

Authors:  William R Rodriguez; Marylyn M Addo; Almas Rathod; Cecily A Fitzpatrick; Xu G Yu; Beth Perkins; Eric S Rosenberg; Marcus Altfeld; Bruce D Walker
Journal:  J Transl Med       Date:  2004-05-21       Impact factor: 5.531

9.  Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients.

Authors:  Amit Kapoor; Beth Shapiro; Robert W Shafer; Nancy Shulman; Soo-Yon Rhee; Eric L Delwart
Journal:  Retrovirology       Date:  2008-01-25       Impact factor: 4.602

10.  Viral population estimation using pyrosequencing.

Authors:  Nicholas Eriksson; Lior Pachter; Yumi Mitsuya; Soo-Yon Rhee; Chunlin Wang; Baback Gharizadeh; Mostafa Ronaghi; Robert W Shafer; Niko Beerenwinkel
Journal:  PLoS Comput Biol       Date:  2008-05-09       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.